ImmunoBrain Checkpoint vs Pyxis Diagnostics

ImmunoBrain Checkpoint vs Pyxis Diagnostics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoBrain Checkpoint is on 42/100 and Pyxis Diagnostics on 51/100.

ImmunoBrain Checkpoint logo
ImmunoBrain CheckpointBiopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.
Try ImmunoBrain Checkpoint
Pyxis Diagnostics logo
Pyxis DiagnosticsDeveloping novel diagnostics to predict patient response to immunotherapy.
Try Pyxis Diagnostics

Where each one leads

ImmunoBrain Checkpoint

  • agent readiness: 36/100 against 22/100
  • domain rating: 35/100 against 2/100
  • headcount: 18 against 3
  • headcount growth: +17.6% against -39.5%
  • LinkedIn following: 1,706 against 398

Pyxis Diagnostics

  • our overall score: 51/100 against 42/100

At a glance

MeasureImmunoBrain CheckpointPyxis Diagnostics
What it isBiopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.Developing novel diagnostics to predict patient response to immunotherapy.
CategoryHealthcare, Immunology, Immunotherapy, AlzheimersHealthcare, Immunotherapy, Oncology, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20162017
HeadquartersTel Aviv, IsraelSan Diego, United States
StatusActiveInactive

Size, funding and growth

MeasureImmunoBrain CheckpointPyxis Diagnostics
Employees183
Headcount growthLast 12 months+17.6%-39.5%
Total fundingNot published$10.0M
Latest roundNot publishedSeed
LinkedIn followers1,706398

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunoBrain CheckpointPyxis Diagnostics
StartupHub scoreOur 0-100 rating42/10051/100
Traction13/10041/100
Team30/10070/100
CommunityNot published15/100
Search visibility28/10026/100
Quality58/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (36/100)F (22/100)
Domain ratingLink authority, 0-10035/1002/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunoBrain CheckpointPyxis Diagnostics
HostingGoogle CloudNot detected
CMSWordPressWix
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4Not detected

ImmunoBrain Checkpoint vs Pyxis Diagnostics: common questions

Which is better, ImmunoBrain Checkpoint or Pyxis Diagnostics?

On our 0-100 score Pyxis Diagnostics rates higher (51/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do ImmunoBrain Checkpoint and Pyxis Diagnostics compare on the numbers?

ImmunoBrain Checkpoint leads on agent readiness (36/100 against 22/100), domain rating (35/100 against 2/100), headcount (18 against 3), headcount growth (+17.6% against -39.5%), LinkedIn following (1,706 against 398). Pyxis Diagnostics leads on our overall score (51/100 against 42/100).

Read the full ImmunoBrain Checkpoint review and pricing or the Pyxis Diagnostics review and pricing. You can also browse other ImmunoBrain Checkpoint alternatives we track.